The Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) aims to strengthen sentinel surveillance for gonococcal antimicrobial resistance (AMR) in s
The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) was developed to address many of GASP’s limitations and strengthen sentinel surveilla
The WHO 2022 report from the Global Antimicrobial Resistance and Use Surveillance System (GLASS) marks the end of the first 5 years of early implementation. The